The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Design of therapeutic proteins with enhanced stability
Open accessAbstract
Therapeutic proteins such as antibodies constitute the most rapidly growing class of pharmaceuticals for use in diverse clinical settings including cancer, chronic inflammatory diseases, kidney transplantation, cardiovascular medicine, and infectious diseases. Unfortunately, they tend to aggregate when stored under the concentrated conditions required in their usage. Aggregation leads to a decrease in antibody activity and could elicit an immunological response. Using full antibody atomistic molecular dynamics simulations, we identify the antibody regions prone to aggregation by using a technology that we developed called spatial aggregation propensity (SAP). SAP identifies the location and size of these aggregation prone regions, and allows us to perform target mutations of those regions to engineer antibodies for stability. We apply this method to therapeutic antibodies and demonstrate the significantly enhanced stability of our mutants compared with the wild type. The technology described here could be used to incorporate developability in a rational way during the screening of antibodies in the discovery phase for several diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of simple potential functions for simulating liquid water
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983) · The Journal of Chemical Physics · doi:10.1063/1.445869 · Cited by 41,298
Scalable molecular dynamics with NAMD
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20289 · Cited by 16,914
CHARMM: A program for macromolecular energy, minimization, and dynamics calculations
Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983) · Journal of Computational Chemistry · doi:10.1002/jcc.540040211 · Cited by 14,944
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Dominant forces in protein folding
Dill, K. A. (1990) · Biochemistry · doi:10.1021/bi00483a001 · Cited by 3,800
Principles of protein-protein interactions
Jones, S., & Thornton, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.13 · Cited by 2,684
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,964
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins
Fernandez-Escamilla, A.-M., Rousseau, F., Schymkowitz, J., & Serrano, L. (2004) · Nature Biotechnology · doi:10.1038/nbt1012 · Cited by 1,658
Canonical structures for the hypervariable regions of immunoglobulins
Chothia, C., & Lesk, A. M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90412-8 · Cited by 1,406
Conformations of immunoglobulin hypervariable regions
Chothia, C., Lesk, A. M., Tramontano, A., Levitt, M., Smith-Gill, S. J., Air, G., Sheriff, S., Padlan, E. A., Davies, D., Tulip, W. R., et al. (1989) · Nature · doi:10.1038/342877a0 · Cited by 1,185
Potent antibody therapeutics by design
Carter, P. J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1837 · Cited by 1,099
Rationalization of the effects of mutations on peptide andprotein aggregation rates
Chiti, F., Stefani, M., Taddei, N., Ramponi, G., & Dobson, C. M. (2003) · Nature · doi:10.1038/nature01891 · Cited by 1,072
INGRAM, V. M. (1957) · Nature · doi:10.1038/180326a0 · Cited by 978
Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design
Saphire, E. O., Parren, P. W. H. I., Pantophlet, R., Zwick, M. B., Morris, G. M., Rudd, P. M., Dwek, R. A., Stanfield, R. L., Burton, D. R., & Wilson, I. A. (2001) · Science · doi:10.1126/science.1061692 · Cited by 942
Challenges in the development of high protein concentration formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20079 · Cited by 882
Standard conformations for the canonical structures of immunoglobulins 1 1Edited by I. A. Wilson
Al-Lazikani, B., Lesk, A. M., & Chothia, C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1354 · Cited by 706
Convergent Solutions to Binding at a Protein-Protein Interface
DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 672
Challenges in the Development of High Protein Concentration Formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2010) · Current Trends in Monoclonal Antibody Development and Manufacturing · doi:10.1007/978-0-387-76643-0_9 · Cited by 657
Structure-Immunogenicity Relationships of Therapeutic Proteins
Hermeling, S., Crommelin, D. J. A., Schellekens, H., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029275.41323.a6 · Cited by 617
Studies of protein‐protein interfaces: A statistical analysis of the hydrophobic effect
Tsai, C., Lin, S. L., Wolfson, H. J., & Nussinov, R. (1997) · Protein Science · doi:10.1002/pro.5560060106 · Cited by 428
A role for surface hydrophobicity in protein‐protein recognition
Young, L., Jernigan, R. L., & Covell, D. G. (1994) · Protein Science · doi:10.1002/pro.5560030501 · Cited by 391
Black, S. D., & Mould, D. R. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90045-u · Cited by 376
Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides
Nguyen, H. D., & Hall, C. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407273101 · Cited by 368
Dissecting the Assembly of Aβ16–22 Amyloid Peptides into Antiparallel β Sheets
Klimov, D. K., & Thirumalai, D. (2003) · Structure · doi:10.1016/s0969-2126(03)00031-5 · Cited by 361
Mimura, Y., Church, S., Ghirlando, R., Ashton, P. R., Dong, S., Goodall, M., Lund, J., & Jefferis, R. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00105-x · Cited by 329
Contribution of Variable Domains to the Stability of Humanized IgG1 Monoclonal Antibodies
Ionescu, R. M., Vlasak, J., Price, C., & Kirchmeier, M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21104 · Cited by 313
Braun, A., Kwee, L., Labow, M. A., & Alsenz, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012193326789 · Cited by 298
Kuttel, M., Brady, J. W., & Naidoo, K. J. (2002) · Journal of Computational Chemistry · doi:10.1002/jcc.10119 · Cited by 298
Gsponer, J., Haberthür, U., & Caflisch, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0835307100 · Cited by 264
Conservation and relative importance of residues across protein-protein interfaces
Guharoy, M., & Chakrabarti, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505425102 · Cited by 258
A broad range of Fab stabilities within a host of therapeutic IgGs
Garber, E., & Demarest, S. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.02.042 · Cited by 229
Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences
Tartaglia, G. G., Cavalli, A., Pellarin, R., & Caflisch, A. (2005) · Protein Science · doi:10.1110/ps.051471205 · Cited by 214
The high resolution crystal structure of deoxyhemoglobin S
Harrington, D. J., Adachi, K., & Royer, W. E. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1253 · Cited by 171
Exploring protein aggregation and self‐propagation using lattice models: Phase diagram and kinetics
Dima, R. I., & Thirumalai, D. (2002) · Protein Science · doi:10.1110/ps.4220102 · Cited by 159
WAM: an improved algorithm for modelling antibodies on the WEB
Whitelegg, N. R. J., & Rees, A. R. (2000) · Protein Engineering, Design and Selection · doi:10.1093/protein/13.12.819 · Cited by 159
Computational models for the prediction of polypeptide aggregation propensity
Caflisch, A. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.07.009 · Cited by 130
What's fueling the biotech engine?
Aggarwal, S. (2007) · Nature Biotechnology · doi:10.1038/nbt1007-1097 · Cited by 118
Harrison, P. M., Chan, H. S., Prusiner, S. B., & Cohen, F. E. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2497 · Cited by 107
Investigation of the Cooperative Structure of Fc Fragments from Myeloma Immunoglobulin G
Tischenko, V. M., Abramov, V. M., & Zav'yalov, V. P. (1998) · Biochemistry · doi:10.1021/bi972647a · Cited by 86
Folding and aggregation of designed proteins
Broglia, R. A., Tiana, G., Pasquali, S., Roman, H. E., & Vigezzi, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.12930 · Cited by 78
Molecular dynamics analysis of a buckyball–antibody complex
Noon, W. H., Kong, Y., & Ma, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022532599 · Cited by 76
Cellmer, T., Bratko, D., Prausnitz, J. M., & Blanch, H. W. (2007) · Trends in biotechnology · doi:10.1016/j.tibtech.2007.03.011 · Cited by 75
Energy transduction during catalysis by Escherichia coli DNA photolyase
Ramsey, A. J., Alderfer, J. L., & Jörns, M. S. (1992) · Biochemistry · doi:10.1021/bi00146a015 · Cited by 37
Cited by
Stability of Protein Pharmaceuticals: An Update
Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0045-6 · Cited by 1,098
Graphene-based wireless bacteria detection on tooth enamel
Mannoor, M. S., Tao, H., Clayton, J. D., Sengupta, A., Kaplan, D. L., Naik, R. R., Verma, N., Omenetto, F. G., & McAlpine, M. C. (2012) · Nature Communications · doi:10.1038/ncomms1767 · Cited by 1,014
Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development
Salo-Ahen, O. M. H., Alanko, I., Bhadane, R., Bonvin, A. M. J. J., Honorato, R. V., Hossain, S., Juffer, A. H., Kabedev, A., Lahtela-Kakkonen, M., Larsen, A. S., et al. (2020) · Processes · doi:10.3390/pr9010071 · Cited by 659
Immunogenicity of therapeutic proteins: Influence of aggregation
Ratanji, K. D., Derrick, J. P., Dearman, R. J., & Kimber, I. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2013.821564 · Cited by 589
The CamSol method of rational design of protein mutants with enhanced solubility
Sormanni, P., Aprile, F. A., & Vendruscolo, M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.09.026 · Cited by 494
Metadata
- Authors
- Chennamsetty, N., Voynov, V., Kayser, V., Helk, B., & Trout, B. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-07-21
- Volume
- 106
- Issue
- 29
- Pages
- 11937-11942
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2067608620
- Cited by
- 598
- References
- 46
- FWCI
- 9.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.